Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer

被引：0
|
作者：
Lai, Lily L.
Chiu, Ken
Lim, Dean
Chao, Joseph
Frankel, Paul Henry
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
    Emmanouilides, Christos
    Sfakiotaki, Georgia
    Androulakis, Nikolaos
    Kalbakis, Kostas
    Christophylakis, Charalambos
    Kalykaki, Antonia
    Vamvakas, Lambros
    Kotsakis, Athanasios
    Agelaki, Sofia
    Diamandidou, Eleni
    Touroutoglou, Nikolaos
    Chatzidakis, Adam
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    Souglakos, John
    BMC CANCER, 2007, 7 (1)
  • [2] Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
    Christos Emmanouilides
    Georgia Sfakiotaki
    Nikolaos Androulakis
    Kostas Kalbakis
    Charalambos Christophylakis
    Antonia Kalykaki
    Lambros Vamvakas
    Athanasios Kotsakis
    Sofia Agelaki
    Eleni Diamandidou
    Nikolaos Touroutoglou
    Adam Chatzidakis
    Vassilis Georgoulias
    Dimitris Mavroudis
    John Souglakos
    BMC Cancer, 7
  • [3] A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
    Carlsson, G.
    Koumarianou, A.
    Guren, T. K.
    Haux, J.
    Katsaounis, P.
    Kentepozidis, N.
    Pfeiffer, P.
    Braendengen, M.
    Mavroudis, D.
    Taffin, H.
    Skintemo, L.
    Tell, R.
    Papadimitriou, C.
    ESMO OPEN, 2022, 7 (05)
  • [4] Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer
    Arkenau, Hendrik-Tobias
    Graeven, Ullrich
    Kubicka, Stephan
    Grothey, Axel
    Englisch-Fritz, Christina
    Kretzschmar, Albrecht
    Greil, Richard
    Freier, Werner
    Seufferlein, Thomas
    Hinke, Axel
    Schmoll, Hans-Joachim
    Schmiegel, Wolff
    Porschen, Rainer
    CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 60 - 64
  • [5] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
    Caponigro, F.
    Lacombe, D.
    Twelves, C.
    Bauer, J.
    Govaerts, A. -S.
    Marreaub, S.
    Milano, A.
    Anthoney, A.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55
  • [6] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [7] Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
    Seium, Y
    Stupp, R
    Ruhstaller, T
    Gervaz, P
    Mentha, G
    Philippe, M
    Allal, A
    Trembleau, C
    Bauer, J
    Morant, R
    Roth, AD
    ANNALS OF ONCOLOGY, 2005, 16 (05) : 762 - 766
  • [8] A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer
    Fakih, Marwan G.
    Pendyala, Lakshmi
    Fetterly, Gerald
    Toth, Karoli
    Zwiebel, James A.
    Espinoza-Delgado, Igor
    Litwin, Alan
    Rustum, Youcef M.
    Ross, Mary Ellen
    Holleran, Julianne L.
    Egorin, Merrill J.
    CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3189 - 3195
  • [9] Phase IB study of Src inhibition with dasatinib in combination with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) and cetuximab in metastatic colorectal cancer
    Kopetz, Scott
    Wolff, Robert
    Eng, Cathy
    Henry, Laura
    Glover, Katrina
    Chang, David
    Overman, Michael
    Gallick, Gary
    Abbruzzese, James
    CANCER RESEARCH, 2008, 68 (09)
  • [10] Phase I Trial of Oxaliplatin, Infiisional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer
    Messersmith, Wells A.
    Jimeno, Antonio
    Jacene, Heather
    Zhao, Ming
    Kulesza, Piotr
    Laheru, Daniel A.
    Kahn, Yasmin
    Spira, Alexander
    Dancey, Janet
    Iacobuzio-Donahue, Christine
    Donehower, Ross C.
    Carducci, Michael
    Rudek, Michelle A.
    Hidalgo, Manuel
    CLINICAL COLORECTAL CANCER, 2010, 9 (05) : 297 - 304
12345